Genetic screening and pharmacogenomics
Rethinking the landscape for genetic marker testing
The increased accessibility of direct-to-consumer (DTC) genetic testing has further fueled the curiosity to decipher an individual’s genetic makeup to gain deeper insight into what their DNA might reveal about them, such as drug metabolism, disease development and ancestry.
To meet both the demand and the need for flexibility as testing firms seek to differentiate their services, LGC, Biosearch Technologies combines multiple instruments into the IntelliQube™ to simplify your screening workflow for walk-away operation, while economically customising to your throughput requirements.
We’re here to help.
Contact us today to learn more about how we can advance your science.